Faruqi & Faruqi Investigates aTyr Pharma Securities Litigation

jueves, 4 de diciembre de 2025, 10:58 am ET1 min de lectura
ATYR--

Faruqi & Faruqi, a leading national securities law firm, is investigating aTyr Pharma for potential securities fraud. Investors who purchased or acquired aTyr securities between January 16, 2025 and September 12, 2025 may be eligible to seek lead plaintiff status in a federal securities class action. The deadline to do so is December 8, 2025. Those interested can contact Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) for more information.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios